Neurogene
NGNE
NGNE
84 hedge funds and large institutions have $193M invested in Neurogene in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 29 increasing their positions, 24 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
-3
Holders Change %
-3.45%
% of All Funds
1.14%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
15
Increased
29
Reduced
24
Closed
17
Calls
$1.19M
Puts
$2.93M
Net Calls
-$1.74M
Net Calls Change
+$713K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$9.51M |
| 2 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$2.8M |
| 3 |
Millennium Management
New York
|
+$1.85M |
| 4 |
CC
Commodore Capital
New York
|
+$1.46M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$1.37M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.65M |
| 2 |
JPMorgan Chase & Co
New York
|
-$4.61M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.82M |
| 4 |
VPC
Vestal Point Capital
New York
|
-$1.83M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.62M |
